Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.14% | 171.45 | 0.7% | $971.15m | |
| ABBV | AbbVie, Inc. | -0.04% | 138.01 | 1.9% | $827.81m | |
| PFE | Pfizer Inc. | 0.20% | 49.35 | 0.9% | $826.43m | |
| LLY | Eli Lilly & Co. | 0.04% | 301.44 | 1.1% | $746.49m | |
| MRK | Merck & Co., Inc. | 0.12% | 87.30 | 0.7% | $738.96m | |
| BMY | Bristol-Myers Squibb Co. | 0.21% | 72.27 | 1.0% | $651.18m | |
| SIGA | SIGA Technologies, Inc. | 3.48% | 24.11 | 0.0% | $427.21m | |
| AZN | AstraZeneca Plc | -0.67% | 65.59 | 1.0% | $378.93m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 218.58 | 8.1% | $241.27m | |
| GSK | GSK Plc | 0.10% | 40.61 | 0.3% | $218.07m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 69.60 | 5.4% | $197.79m | |
| SGEN | Seagen Inc. | 1.21% | 177.93 | 5.7% | $191.02m | |
| NVS | Novartis AG | 0.50% | 86.00 | 0.2% | $174.26m | |
| RGEN | Repligen Corp. | 0.00% | 246.27 | 6.7% | $155.75m | |
| NVO | Novo Nordisk A/S | -0.46% | 102.74 | 0.1% | $152.22m |
Company Profile
Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company engaged in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III and Loren David Walensky on August 6, 2001 and is headquartered in Watertown, MA.